Chemed Corp

CHENYSECIK 19584HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 231 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Chemed Corp, Reports and events
Filed	Form	What it is	Accession number
2018-10-2916:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-18-002183
2018-10-0114:54 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-18-002002
2018-07-3009:59 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001157523-18-001583
2018-07-2516:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-18-001525
2018-06-2212:06 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001157523-18-001331
2018-05-2309:32 ET	8-K	5.07 Shareholder vote results	0001157523-18-001180
2018-04-2709:01 ET	10-Q	Quarterly reportPeriod 2018-03-31	0001157523-18-000853
2018-04-1916:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-18-000758
2018-04-1110:54 ET	DEF 14A	Proxy statementPeriod 2018-05-21	0001157523-18-000697
2018-03-0612:08 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-18-000503
2018-02-2610:34 ET	10-K	Annual reportPeriod 2017-12-31	0001157523-18-000411
2018-02-2316:23 ET	SC 13D/A	Ownership report, active investor, amended	0000807249-18-000033
2018-02-1416:49 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-18-000326
2017-11-0217:00 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001157523-17-002997
2017-10-2711:17 ET	10-Q	Quarterly reportPeriod 2017-09-30	0001157523-17-002853
2017-10-2616:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-17-002836
2017-07-3114:57 ET	10-Q	Quarterly reportPeriod 2017-06-30	0001157523-17-002178
2017-07-2516:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-17-002065
2017-05-1709:42 ET	8-K	5.07 Shareholder vote results	0001157523-17-001596
2017-04-2807:58 ET	10-Q	Quarterly reportPeriod 2017-03-31	0001157523-17-001278
2017-04-2616:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-17-001207
2017-04-1009:50 ET	DEF 14A	Proxy statementPeriod 2017-05-15	0001157523-17-001005
2017-04-0310:07 ET	8-K	5.02 Departure or appointment of officers or directors	0001157523-17-000957
2017-03-1311:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-17-000785
2017-03-0714:05 ET	SC 13D/A	Ownership report, active investor, amended	0000807249-17-000051
2017-02-2712:13 ET	10-K	Annual reportPeriod 2016-12-31	0001157523-17-000638
2017-02-1713:02 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001157523-17-000541
2017-02-1516:46 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-17-000511
2016-11-0108:01 ET	10-Q	Quarterly reportPeriod 2016-09-30	0001157523-16-007144
2016-10-2616:21 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-16-007033
2016-07-2908:28 ET	10-Q	Quarterly reportPeriod 2016-06-30	0001157523-16-006319
2016-07-2516:25 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-16-006164
2016-06-0907:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001157523-16-005842
2016-05-1811:14 ET	8-K	5.07 Shareholder vote results	0001157523-16-005660
2016-05-0211:15 ET	10-Q	Quarterly reportPeriod 2016-03-31	0001157523-16-005358
2016-04-2816:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-16-005317
2016-04-0709:24 ET	DEF 14A	Proxy statementPeriod 2016-05-16	0001157523-16-005068
2016-03-1408:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-16-004912
2016-02-2610:14 ET	10-K	Annual reportPeriod 2015-12-31	0001157523-16-004755
2016-02-1913:22 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001157523-16-004649
2016-02-1716:31 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-16-004622
2015-10-3008:16 ET	10-Q	Quarterly reportPeriod 2015-09-30	0001157523-15-003582
2015-10-2216:23 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-15-003398
2015-07-3107:31 ET	10-Q	Quarterly reportPeriod 2015-06-30	0001157523-15-002664
2015-07-2316:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-15-002483
2015-05-2013:44 ET	8-K	5.07 Shareholder vote results	0001157523-15-001869
2015-05-0108:50 ET	10-Q	Quarterly reportPeriod 2015-03-31	0001157523-15-001512
2015-04-2816:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-15-001374
2015-04-0708:49 ET	DEF 14A	Proxy statementPeriod 2015-05-18	0001157523-15-001104
2015-03-1313:47 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-15-000925

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.